ENTITY
Adagene Inc

Adagene Inc (ADAG US)

2
Analysis
Health CareChina
Adagene Inc. operates as a biotechnology company. The Company focuses on the development of antibodies to cancer patients. Adagene serves patients in the United States and China.
more
Refresh
05 Feb 2022 18:39

Meihua International Medical Technologies Pre-IPO: Risks Overshadow Cheap Valuation

Meihua plans to raise $50 million by offering 5 million shares. At midpoint, the company would command a market cap of $250 million. Shares are...

Logo
355 Views
Share
bullishAdagene Inc
27 Jan 2021 09:52

Pre-IPO Adagene Inc (ADAG US) - Advanced Technology but Still Take Time for Commercialization

This article analyzed Adagene Inc. in terms of the DPL platform, the core products in the pipeline (ADG106, ADG126 and ADG116), the financial...

Logo
274 Views
Share
x